FTO and breast cancer: (iv) Chen et al. [67] showed that m6A RNA methylation regulators are closely related to malignant clinico-pathological features of breast cancer and identified a prognostic bio-signature, composed of the FTO, YTHDC1 and WTAP m6A RNA methylation regulators.